Society for Endocrinology guidance on use of dopamine agonists in endocrine disorders

03 Oct 2007


The Society for Endocrinology has recently issued a new position statement on the use of dopamine agonists for the treatment of endocrine disorders. The guidance can be viewed at the link below.

SfE position statement


Share this story